Vaccine compositions and methods of modulating immune responses

Details Vaccine compositions and methods of modulating immune responses Vaccine compositions and methods of modulating immune responses

2008-05-13

2008-05-13

Saunders, David A. (Department: 1644)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Fusion protein or fusion polypeptide

C514S04400A

Reexamination Certificate

active

10262828

ABSTRACT:
The invention provides compositions and methods for modulating immune responses in subjects. The invention is based, at least in part, on the discovery that an in-frame translation fusion of an antigen with an APC binding domain of an opsonin forms a molecule, that is, a fusion polypeptide, which when administered to a subject modulates an immune response to the antigen.

REFERENCES:
patent: 5891432 (1999-04-01), Hoo
patent: 6277368 (2001-08-01), Hiserodt et al.
patent: 6632436 (2003-10-01), Segal
patent: 2002/0076392 (2002-06-01), Hoo
Arvieux, et al. (1988). “Antigen-bound C3b and C4b Enhance Antigen-Presenting Cell Function in Activation of Human T-Cell Clones,”Immunology65:229-235.
Baier, et al. (1995). “Immunogenic Targeting of Recombinant Peptide Vaccines to Human Atigen-Presenting Cells by Chimeric Anti-HLA-DR and Anti-Surface Immunoglobulin D Antibody Fab Fragments In Vitro,”Journal of Virology69:2357-2365.
Berg, et al. (1994). “Comparing Macrophages and Dendritic Lwukocytes as Antigen-Presenting Cells for Humoral Responses In Vivo by Antigen Targeting,”Eur J Immunol24:1262-1268.
Carayanniotis, et al. (1987). “Adjuvant-Free IgG Responses Induced with Antigen Coupled to Antibodies Against Class II MHC,”Nature327:59-61.
Chu, et al. (1993). “Receptor-Mediated Antigen Delivery into Macrophages,”Journal of Immunology150:48-58.
Chu, et al. (1994). “Adjuvant-Free In Vivo Targeting,”Journal of Immunology1538-1545.
Dempsey, et al. (1996). “C3d of Complement as a Molecular Adjubant: Bridging Innate and Acquired Immunity,”Science271:348-350.
Estrada, et al. (1995). “Intestinal Immunization of Mice with Antigen Conjugated to Anti-MHC Class II Antibodies,”Vaccine13(10):901-907.
Gossselin, et al. (1992). “Enhanced Antigen Presentation Using Human Fcγ Receptor (Monocyte/Macrophage)-Specific Immunogens,”Journal of Immunology149(11):3477-3481.
Jacquier-Sarlin, et al. (1995). “Modulation of Antigen Processing and Presentation by Covalently Linked Complement C3b Fragment,”Immunology84:164-170.
Liu, et al. (1992). “FCγ RI-Targeted Fusion Proteins Result in Efficient Presentation by Human Monocytes of Antigenic and Antagonis T Cell Epitopes,”J. Clin. Invest.98(9):2001-2007.
Snider, et al. (1989). “Efficiency of Antigen Presentation Ater Antigen Targeting to Surface IgD, IgM, MHC, FcγRII and B220 Molecules on Murine Splenic B Cells,”Journal of Immunology143:59-65.
Squire, et al. (1994). “Antigen Presentation is Enhanced by Targeting Antigen to the FcεRII by Antigen-Anti-FcεRII Conjugates,”Journal of Immunology4388-4396.

Affiliated with

Also associated with

Rating

Vaccine compositions and methods of modulating immune responses does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vaccine compositions and methods of modulating immune responses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine compositions and methods of modulating immune responses will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3923074